These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34117362)

  • 1. The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers.
    Kimura H; Sada R; Takada N; Harada A; Doki Y; Eguchi H; Yamamoto H; Kikuchi A
    Oncogene; 2021 Jul; 40(26):4486-4502. PubMed ID: 34117362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
    Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
    Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXM1 Promotes Malignant Proliferation of Esophageal Squamous Cell Carcinoma Through Transcriptional Activating CDC6.
    Chen X; Chen J; Yu X; Lin G; Chen T
    DNA Cell Biol; 2022 Jul; 41(7):671-682. PubMed ID: 35639418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1.
    Zhong Y; Wang Z; Fu B; Pan F; Yachida S; Dhara M; Albesiano E; Li L; Naito Y; Vilardell F; Cummings C; Martinelli P; Li A; Yonescu R; Ma Q; Griffin CA; Real FX; Iacobuzio-Donahue CA
    PLoS One; 2011; 6(7):e22129. PubMed ID: 21811562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abnormal expression of circ-ARAP2 promotes ESCC progression through regulating miR-761/FOXM1 axis-mediated stemness and the endothelial-mesenchymal transition.
    Xu P; Wang L; Liu Q; Gao P; Hu F; Xie X; Jiang L; Bi R; Ding F; Yang Q; Xiao H
    J Transl Med; 2022 Jul; 20(1):318. PubMed ID: 35842667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.
    Kimura H; Fumoto K; Shojima K; Nojima S; Osugi Y; Tomihara H; Eguchi H; Shintani Y; Endo H; Inoue M; Doki Y; Okumura M; Morii E; Kikuchi A
    J Clin Invest; 2016 Jul; 126(7):2689-705. PubMed ID: 27322059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
    Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
    Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activation of asparagine synthetase by the transcription factor FOXM1 plays a pivotal role in the initiation and progression of ESCC.
    Lian JJ; Li ZX; Lin HL; Sun MC; Wu H; Feng AQ; Fang K; Wang XY; Xu AP; Chu Y; Zhang L; Chen T; Xu MD
    J Gene Med; 2024 Oct; 26(10):e3741. PubMed ID: 39357835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CKAP4, a DKK1 Receptor, Is a Biomarker in Exosomes Derived from Pancreatic Cancer and a Molecular Target for Therapy.
    Kimura H; Yamamoto H; Harada T; Fumoto K; Osugi Y; Sada R; Maehara N; Hikita H; Mori S; Eguchi H; Ikawa M; Takehara T; Kikuchi A
    Clin Cancer Res; 2019 Mar; 25(6):1936-1947. PubMed ID: 30610103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
    Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mir-320b Inhibits Pancreatic Cancer Cell Proliferation by Targeting FOXM1.
    Jingyang Z; Jinhui C; Lu X; Weizhong Y; Yunjiu L; Haihong W; Wuyuan Z
    Curr Pharm Biotechnol; 2021; 22(8):1106-1113. PubMed ID: 32942974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C; Shi J; Li Q; Li Z; Lou C; Zhao Q; Zhu Y; Zhan F; Lian J; Wang B; Guan X; Fang L; Li Z; Wang Y; Zhou B; Yao Y; Zhang Y
    Clin Sci (Lond); 2019 Mar; 133(5):645-663. PubMed ID: 30782607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
    Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
    Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 18. FOXM1c promotes oesophageal cancer metastasis by transcriptionally regulating IRF1 expression.
    Zhou Y; Wang Q; Chu L; Dai W; Zhang X; Chen J; Zhang L; Ding P; Zhang X; Gu H; Zhang P; Li L; Zhang W; Li L; Lv X; Zhou D; Cai G; Chen L; Zhao K; Hu W
    Cell Prolif; 2019 Mar; 52(2):e12553. PubMed ID: 30485581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long intergenic non‑coding RNA LINC01232 contributes to esophageal squamous cell carcinoma progression by sequestering microRNA‑654‑3p and consequently promoting hepatoma‑derived growth factor expression.
    Zhao M; Cui H; Zhao B; Li M; Man H
    Int J Mol Med; 2020 Dec; 46(6):2007-2018. PubMed ID: 33125097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6.
    Sada R; Kimura H; Fukata Y; Fukata M; Yamamoto H; Kikuchi A
    Sci Signal; 2019 Nov; 12(608):. PubMed ID: 31744930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.